Kenya's HIV Prevention Jab Leaves Hardest-Hit Behind
Kenya's rollout of the breakthrough HIV prevention drug lenacapavir is failing to reach high-risk areas like Kibera, where barriers such as transport costs and lack of local access hinder equitable distribution.


